Company Filing History:
Years Active: 2018-2019
Title: The Innovative Contributions of Pilgrim Jackson
Introduction
Pilgrim Jackson is a dedicated inventor based in San Diego, CA, known for his remarkable contributions to the field of biotechnology. With two patents to his name, Jackson is making significant strides in the realm of medical innovation, particularly in cancer treatment and immune modulation.
Latest Patents
Jackson's latest patents include the development of PD-1 binding proteins and methods of use thereof. This innovation encompasses compositions, methods, and uses involving antibodies that specifically bind to Programmed Death-1 (PD-1), aimed at modulating the expression and activity of PD-1. Furthermore, he has developed methods for determining drug efficacy using cereblon-associated proteins, which utilize these proteins as biomarkers for clinical sensitivity to cancer, inflammatory diseases, and patient responses to drug treatments.
Career Highlights
Currently, Pilgrim Jackson works with the Celgene Corporation, a prominent player in the biotechnology sector. His role at the company has allowed him to delve deeper into his research and apply his knowledge to real-world applications, pushing the boundaries of what is possible in medical science.
Collaborations
Throughout his career, Jackson has collaborated with several esteemed professionals, including Brydon L. Bennett and Philip Chamberlain. These partnerships have enhanced his research capabilities and contributed to the successful development and refinement of his patented technologies.
Conclusion
Pilgrim Jackson exemplifies the spirit of innovation within the scientific community. His patents and collaborative efforts highlight the vital intersection of research and practical application in biotechnology, promising advancements that could have a lasting impact on healthcare and disease treatment.